References
- R. K. Verma and S. Garg, Compatibility studies between isosorbide mononitrate and selected excipients used in the development of extended release formulations, J. Pharm. Biomed. Anal. 35 (2004) 449-458; DOI: 10.1016/j.jpba.2004.01.012.
- E. C. V. Tonder, A. P. Lotter and S. A. Botha, Compatibility study between doxylamine succinate with other drugs and excipients using differential scanning calorimetry, Drug Dev. Ind. Pharm. 16 (1990) 2125-2133; DOI: 10.3109/03639049009023644.
- S. Venkataram, M. Khohlokwane and S. H. Wallis, Differential scanning calorimetry as a quick scanning technique for solid state stability studies, Drug Dev. Ind. Pharm. 21 (1995) 847-855; DOI: 10.3109/03639049509026649.
- R. Kandarapu, V. Grover, H. P. S. Chawla and S. Garg, Evaluation of compatibility of ketorolac tromethamine with selected polymers and common tablet excipients by thermal and isothermal stress testing, S.T.P. Pharm. Sci. 11 (2001) 449-457.
- P. Mura, A. Manderioli, G. Bramanti, S. Furlanetto and S. Pinzauti, Utilization of differential scanning calorimetry as a screening technique to determine the compatibility of ketoprofen with excipients, Int. J. Pharm. 119 (1995) 71-79; DOI: 10.1016/0378-5173(94)00374.
- P. Mura, M. T. Faucci, A. Manderioli, G. Bramanti and L. Ceccarelli, Compatibility study between ibuproxam and pharmaceutical excipients using differential scanning calorimetry, hot-stage microscopy and scanning electron microscopy, J. Pharm. Biomed. Anal. 18 (1998) 151-163; DOI: 10.1016/S0731-7085(98)00171.
- S. A. Botha and A. P. Lotter, Compatibility study between naproxen and tablet excipients using differential scanning calorimetry, Drug Dev. Ind. Pharm. 16 (1990) 673-683; DOI: 10.3109/03639049009104410.
- A. T. Serajuddin, A. B. Thakur, R. N. Ghoshal, M. G. Fakes, S. A. Ranadive, K. R. Morris and S. A. Varia, Selection of solid dosage form composition through drug-excipient compatibility testing, J. Pharm. Sci. 88 (1999) 696-704.
- L. Gu, R. G. Strickley, L. H. Chi and Z. T. Chowhan, Drug-excipient incompatibility studies of the dipeptide angiotensin-converting enzyme inhibitor, moexipril hydrochloride: dry powder vs wet granulation, Pharm. Res. 7 (1990) 379-383.
- J. F. McLeod, Clinical pharmacokinetics of nateglinide: a rapidly-absorbed, short-acting insulinotropic agent, Clin. Pharmacokinet. 43 (2004) 97-120.
- M. E. Sangalli, P. Giunchedi, P. Colombo, U. Conte, A. Gazzaniga and A. La Manna, Cross-linked sodium carboxymethylcellulose as a carrier for dissolution rate improvement of drugs, Boll. Chim. Farm. 128 (1989) 242-247.
- US Pharmacopoeia 30, National Formulary 25, USP Convention, Rockville 2007.
- U.S. Department of Health and Human Services, Food and Drug Administration Center for Drug Evaluation and Research, Guidance for Industry: Dissolution Testing of Immediate Release Solid Oral Dosage Forms, FDA CDER, Rockville (MD) 1997; Guidances/UCM070237; access date May 15, 2010.
- J. W. Moore and H. H. Flanner, Mathematical comparison of dissolution profiles, Pharm. Technol. 20 (1996) 64-74.
- A. Smith, Use of thermal analysis in predicting drug-excipient interactions, Anal. Proc. 19 (1982) 559-561.
- T. Durig and A. R. Fassihi, Identification of stabilizing and destabilizing effects of excipient-drug interactions in solid dosage form design, Int. J. Pharm. 97 (1993) 161-170.